Figure 4
From: Tumor-specific delivery of biologics by a novel T-cell line HOZOT
HOZOT cell–mediated protection of OBP-401/F35 from antibody-mediated virus neutralization.
(a) Phase-contrast and fluorescence images of SW620 cells treated with mock, OBP-401/F35, or virus-loaded HOZOT-401/F35 cells in the presence or absence of neutralizing antibody. Scale bars: 200 μm. (b) SW620 cells treated with mock, OBP-401/F35, or virus-loaded HOZOT-401/F35 cells. Cell viability was calculated relative to that of the mock-treated group, which was set at 100%. Cell viability data are expressed as mean values ± SD (n = 5). *P < 0.05. N.S., not significant.
